Skip to main content
SLS
NASDAQ Life Sciences

$150M Equity Offering Launched Days After REGAL Trial Win

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$18.03
Mkt Cap
$1.523B
52W Low
$1.39
52W High
$24.89
52W Position info
1197% above low
Off High info
28% below high
Rel. Volume info
13× avg
Market data snapshot near publication time

SLS has more than doubled off its 52-week low of $1.39 on elevated volume (13× avg).

Summary

SELLAS launched a $150.0 million underwritten public offering of common stock, with a 30-day option for up to $22.5 million more. J.P. Morgan and TD Cowen are joint book-running managers. The raise is large relative to the company and comes just hours after the stock jumped on positive Phase 3 REGAL overall survival data, so expect dilution pressure and a likely discount to the $18.03 last price once terms are set. The company already had $134.7 million in cash as of Q3, enough for at least twelve months, so this is opportunistic capital ahead of BLA preparation rather than a liquidity scramble. Pricing terms and the final size are the next hard data points.

At the time of this announcement, SLS was trading at $18.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $1.39 to $24.89. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SLS - Latest Insights

SLS
Nov 17, 2026, 10:09 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $20.45
Real-time Price: $17.00 info
Change: -$3.45 (-17%) info
Market Cap: $1.523B info
SLS
Nov 17, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $8.00
Real-time Price: $17.00 info
Change: +$9.00 (+112%) info
Market Cap: $1.523B info
SLS
Nov 12, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $17.00 info
Change: +$8.99 (+112%) info
Market Cap: $1.523B info
SLS
Oct 28, 2026, 8:35 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $12.75
Real-time Price: $17.00 info
Change: +$4.25 (+33%) info
Market Cap: $1.523B info
SLS
Oct 01, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $12.36
Real-time Price: $17.00 info
Change: +$4.64 (+38%) info
Market Cap: $1.523B info